Orbit Discovery

Orbit Discovery is a peptide drug discovery company spun out from the University of Oxford which has developed a proprietary peptide synthesis and functional screening platform that promises to find new peptide drugs for difficult targets.

This technology allows Orbit to address high-value targets like G-protein coupled receptors (GPCRs) and T-cell receptors (TCRs) with a growing library of over 1 million natural and non-natural peptides. Orbit is commercialising the platform by performing early stage lead-discovery for pharmaceutical and biopharmaceutical drug development programmes, currently with three large pharma partners.

Visit website